Healthcare [ 5/13 ] | Biotechnology [ 44/159 ]
NASDAQ | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 12, 23 | 0 Increased by +100% | -0.6 Increased by +100% |
| Sep 29, 23 | 0 Increased by +100% | -1 Increased by +100% |
| May 1, 23 | -0.08 Increased by +34.21% | -0.07 Decreased by -14.29% |
| Mar 30, 23 | -0.08 Decreased by -156.41% | -0.07 Decreased by -14.29% |
| Dec 30, 22 | -0.04 Increased by +73.65% | -0.04 |
| Jul 20, 22 | -0.1 Decreased by -866% | - |
| May 16, 22 | -0.12 Decreased by -380.83% | - |
| Dec 3, 21 | -0.03 Increased by +88.76% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 23 | N/A Decreased by N/A% | N/A Increased by +100% | - - |
| Mar 31, 23 | N/A Decreased by N/A% | N/A Increased by +100% | - - |
| Dec 31, 22 | N/A Decreased by N/A% | N/A Increased by +100% | - - |
| Sep 30, 22 | N/A Decreased by N/A% | N/A Increased by +100% | - - |
| Jun 30, 22 | 0 Decreased by N/A% | -5.54 M Decreased by -26.7% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0 Decreased by N/A% | -5.11 M Increased by +12.5% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0 Decreased by N/A% | -5.61 M Increased by +17.72% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 21 | 0 Decreased by N/A% | -1.43 M Decreased by -198.83% | Decreased by N/A% Decreased by N/A% |
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid, as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration. The company is based in London, the United Kingdom.